v3.19.3.a.u2
CONDENSED CONSOLIDATING FINANCIAL INFORMATION
12 Months Ended
Dec. 31, 2019
CONDENSED CONSOLIDATING FINANCIAL INFORMATION  
CONDENSED CONSOLIDATING FINANCIAL INFORMATION

NOTE 19—CONDENSED CONSOLIDATING FINANCIAL INFORMATION

The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X Rule 3-10, Financial statements of guarantors and issuers of guaranteed securities registered or being registered. Each of the subsidiary guarantors are 100% owned by Holdings. The subsidiary guarantees of the Company’s Convertible Notes due 2024, the Sterling Notes due 2024, the Notes due 2025, Notes due 2026, and the Notes due 2027 are full and unconditional and joint and several and subject to customary release provisions. The Company and its subsidiary guarantors’ investments in its consolidated subsidiaries are presented under the equity method of accounting.

The condensed consolidating information for the guarantors/non-guarantors has been retrospectively revised based on the structure that exists as of December 31, 2019 and reflecting changes as a result of the Sixth Amendment.

Consolidating Statement of Operations

Year Ended December 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Revenues

    

    

    

    

    

    

    

    

    

    

Admissions

$

$

2,388.2

$

913.1

$

$

3,301.3

Food and beverage

 

 

1,348.0

 

371.6

 

 

1,719.6

Other theatre

 

 

287.1

 

163.0

 

 

450.1

Total revenues

 

 

4,023.3

 

1,447.7

 

 

5,471.0

Operating costs and expenses

Film exhibition costs

 

 

1,311.5

 

387.6

 

 

1,699.1

Food and beverage costs

 

 

193.8

 

84.9

 

 

278.7

Operating expense, excluding depreciation and amortization

 

 

1,215.5

 

471.1

 

 

1,686.6

Rent

 

 

708.2

 

259.6

 

 

967.8

General and administrative:

Merger, acquisition and other costs

 

 

6.5

 

9.0

 

 

15.5

Other, excluding depreciation and amortization

 

 

86.4

 

66.6

 

 

153.0

Depreciation and amortization

 

 

340.4

 

109.6

 

 

450.0

Impairment of long-lived assets

76.6

7.7

84.3

Operating costs and expenses

 

 

3,938.9

 

1,396.1

 

 

5,335.0

Operating income

 

 

84.4

 

51.6

 

 

136.0

Other expense (income):

Equity in net loss of subsidiaries

 

382.9

 

151.3

 

 

(534.2)

 

Other expense (income)

(5.2)

18.5

0.1

13.4

Interest expense:

Corporate borrowings

 

290.8

 

293.0

 

3.0

 

(294.0)

 

292.8

Financing lease obligations

 

 

2.3

 

5.3

 

 

7.6

Non-cash NCM exhibitor service agreement

40.4

40.4

Intercompany interest expense

244.1

(244.1)

Equity in earnings of non-consolidated entities

 

 

(29.1)

 

(1.5)

 

 

(30.6)

Investment income

 

(519.4)

 

(21.0)

 

(13.7)

 

538.1

 

(16.0)

Total other expense, net

 

149.1

 

455.4

 

237.3

 

(534.2)

 

307.6

Loss before income taxes

 

(149.1)

 

(371.0)

 

(185.7)

 

534.2

 

(171.6)

Income tax provision (benefit)

 

 

11.9

 

(34.4)

 

 

(22.5)

Net loss

$

(149.1)

$

(382.9)

$

(151.3)

$

534.2

$

(149.1)

Consolidating Statement of Operations

Year Ended December 31, 2018:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Revenues

    

    

    

    

    

    

    

    

    

    

Admissions

$

$

2,441.5

$

943.5

$

$

3,385.0

Food and beverage

 

 

1,321.3

 

350.2

 

 

1,671.5

Other theatre

 

 

250.4

 

153.9

 

 

404.3

Total revenues

 

 

4,013.2

 

1,447.6

 

 

5,460.8

Operating costs and expenses

Film exhibition costs

 

 

1,323.1

 

387.1

 

 

1,710.2

Food and beverage costs

 

 

190.3

 

80.6

 

 

270.9

Operating expense, excluding depreciation and amortization

 

 

1,162.2

 

492.5

 

 

1,654.7

Rent

 

 

584.4

 

213.4

 

 

797.8

General and administrative:

Merger, acquisition and other costs

 

 

16.8

 

14.5

 

 

31.3

Other, excluding depreciation and amortization

 

 

112.5

 

66.8

 

 

179.3

Depreciation and amortization

 

 

384.0

 

153.8

 

 

537.8

Impairment of long-lived assets

8.1

5.7

13.8

Operating costs and expenses

 

 

3,781.4

 

1,414.4

 

 

5,195.8

Operating income

 

 

231.8

 

33.2

 

 

265.0

Other expense (income):

Equity in net earnings of subsidiaries

 

(14.5)

 

(13.7)

 

 

28.2

 

Other expense (income)

(110.5)

1.7

0.7

(108.1)

Interest expense:

Corporate borrowings

 

256.7

 

263.1

 

5.9

 

(263.4)

 

262.3

Capital and financing lease obligations

 

 

17.2

 

21.3

 

 

38.5

Non-cash NCM exhibitor service agreement

41.5

41.5

Equity in earnings of non-consolidated entities

 

 

(81.5)

 

(5.2)

 

 

(86.7)

Investment income

 

(241.8)

 

(27.1)

 

(0.7)

 

263.4

 

(6.2)

Total other expense (income), net

 

(110.1)

 

201.2

 

22.0

 

28.2

 

141.3

Earnings before income taxes

 

110.1

 

30.6

 

11.2

 

(28.2)

 

123.7

Income tax provision (benefit)

 

 

16.1

 

(2.5)

 

 

13.6

Net earnings

$

110.1

$

14.5

$

13.7

$

(28.2)

$

110.1

Consolidating Statement of Operations

Year Ended December 31, 2017:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Revenues

    

    

    

    

    

    

    

    

    

    

Admissions

$

$

2,330.9

$

898.6

$

$

3,229.5

Food and beverage

 

 

1,220.1

 

328.3

 

 

1,548.4

Other theatre

 

 

172.5

 

128.8

 

 

301.3

Total revenues

 

 

3,723.5

 

1,355.7

 

 

5,079.2

Operating costs and expenses

Film exhibition costs

 

 

1,224.7

 

379.6

 

 

1,604.3

Food and beverage costs

 

 

176.6

 

75.5

 

 

252.1

Operating expense, excluding depreciation and amortization

 

 

1,100.6

 

447.4

 

 

1,548.0

Rent

 

 

594.0

 

200.4

 

 

794.4

General and administrative:

Merger, acquisition and other costs

 

 

58.3

 

4.7

 

 

63.0

Other, excluding depreciation and amortization

 

2.0

 

82.7

 

48.5

 

 

133.2

Depreciation and amortization

 

 

404.2

 

134.4

 

 

538.6

Impairment of long-lived assets

 

43.6

43.6

Operating costs and expenses

 

2.0

 

3,684.7

 

1,290.5

 

 

4,977.2

Operating income (loss)

 

(2.0)

 

38.8

 

65.2

 

 

102.0

Other expense (income):

Equity in net (earnings) loss of subsidiaries

 

472.5

 

(45.1)

 

 

(427.4)

 

Other expense (income)

(1.7)

0.2

(1.5)

Interest expense:

Corporate borrowings

 

230.3

 

239.0

 

1.3

 

(239.0)

 

231.6

Capital and financing lease obligations

 

 

20.0

 

22.4

 

 

42.4

Equity in earnings of non-consolidated entities

 

 

187.8

 

(2.6)

 

 

185.2

Investment income

 

(217.6)

 

(43.0)

 

(1.0)

 

239.0

 

(22.6)

Total other expense, net

 

485.2

 

357.0

 

20.3

 

(427.4)

 

435.1

Earnings (loss) before income taxes

 

(487.2)

 

(318.2)

 

44.9

 

427.4

 

(333.1)

Income tax provision (benefit)

 

 

154.3

 

(0.2)

 

 

154.1

Net earnings (loss)

$

(487.2)

$

(472.5)

$

45.1

$

427.4

$

(487.2)

Consolidating Statement of Comprehensive Loss

Year Ended December 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

 

(In millions)

    

Holdings

    

Guarantors

    

Non-Guarantors

   

Adjustments

    

Holdings

 

Net loss

    

$

(149.1)

    

$

(382.9)

    

$

(151.3)

    

$

534.2

    

$

(149.1)

Other comprehensive income (loss):

Equity in other comprehensive loss of subsidiaries

 

(31.6)

 

17.2

 

 

14.4

 

Unrealized foreign currency translation adjustment, net of tax

 

(44.1)

 

27.6

 

 

(16.5)

Realized loss on foreign currency transactions, net of tax

 

 

0.5

 

 

 

0.5

Pension and other benefit adjustments:

Net loss arising during the period, net of tax

(5.1)

(10.4)

(15.5)

Equity method investee's cash flow hedge:

Unrealized net holding loss arising during the period, net of tax

 

 

(0.1)

 

 

 

(0.1)

Other comprehensive income (loss)

 

(31.6)

 

(31.6)

 

17.2

 

14.4

 

(31.6)

Total comprehensive loss

$

(180.7)

$

(414.5)

$

(134.1)

$

548.6

$

(180.7)

Consolidating Statement of Comprehensive Loss

Year Ended December 31, 2018:

Subsidiary

Subsidiary

Consolidating

Consolidated

 

(In millions)

    

Holdings

    

Guarantors

    

Non-Guarantors

    

Adjustments

    

Holdings

 

Net earnings

    

$

110.1

    

$

14.5

    

$

13.7

    

$

(28.2)

    

$

110.1

Other comprehensive loss:

Equity in other comprehensive loss of subsidiaries

 

(124.5)

 

(99.1)

 

 

223.6

 

Unrealized foreign currency translation adjustment, net of tax

 

 

(30.7)

 

(97.0)

 

 

(127.7)

Realized loss on foreign currency transactions reclassified into other expense, net of tax

1.0

1.0

Pension and other benefit adjustments:

Net gain (loss) arising during the period, net of tax

 

 

6.3

 

(2.1)

 

 

4.2

Equity method investee's cash flow hedge:

 

Unrealized net holding gain arising during the period, net of tax

 

 

0.2

 

 

 

0.2

Realized net gain reclassified to equity in earnings of non-consolidated entities, net of tax

 

 

(2.2)

 

 

 

(2.2)

Other comprehensive loss

 

(124.5)

 

(124.5)

 

(99.1)

 

223.6

 

(124.5)

Total comprehensive loss

$

(14.4)

$

(110.0)

$

(85.4)

$

195.4

$

(14.4)

Consolidating Statement of Comprehensive Income (Loss)

Year Ended December 31, 2017:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

    

Holdings

    

Guarantors

    

Non-Guarantors

    

Adjustments

    

Holdings

Net earnings (loss)

    

$

(487.2)

    

$

(472.5)

    

$

45.1

    

$

427.4

    

$

(487.2)

Other comprehensive income (loss)

Equity in other comprehensive income of subsidiaries

 

128.1

 

112.1

 

 

(240.2)

 

Unrealized foreign currency translation adjustment, net of tax

 

 

22.0

 

109.7

 

 

131.7

Pension and other benefit adjustments:

Net gain (loss) arising during the period, net of tax

 

 

(5.4)

 

2.4

 

 

(3.0)

Marketable securities:

Unrealized net holding gain arising during the period, net of tax

 

 

0.7

 

 

 

0.7

Realized net gain reclassified into net investment income, net of tax

 

 

(0.4)

 

 

 

(0.4)

Equity method investee's cash flow hedge:

 

Realized net gain reclassified into equity in earnings of non-consolidated entities, net of tax

 

 

(0.9)

 

 

 

(0.9)

Other comprehensive income

 

128.1

 

128.1

 

112.1

 

(240.2)

 

128.1

Total comprehensive income (loss)

$

(359.1)

$

(344.4)

$

157.2

$

187.2

$

(359.1)

Consolidating Balance Sheet

As of December 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Assets

    

    

    

    

    

    

    

    

    

    

Current assets:

Cash and cash equivalents

$

0.3

$

94.9

$

169.8

$

$

265.0

Restricted cash

10.5

10.5

Receivables, net

 

 

160.1

 

104.0

 

(9.9)

 

254.2

Other current assets

 

 

108.5

 

34.9

 

 

143.4

Total current assets

 

0.3

 

363.5

 

319.2

 

(9.9)

 

673.1

Investment in equity of subsidiaries

 

452.6

 

1,962.8

 

 

(2,415.4)

 

Property, net

 

 

1,969.3

 

679.9

 

 

2,649.2

Operating lease right-of-use assets, net

3,491.8

1,304.2

4,796.0

Intangible assets, net

 

 

130.6

 

64.7

 

 

195.3

Intercompany advances

 

5,488.0

 

(5,097.7)

 

(390.3)

 

 

Goodwill

 

(2.1)

 

3,074.7

 

1,716.5

 

 

4,789.1

Deferred tax asset, net

 

 

 

70.1

 

 

70.1

Other long-term assets

 

47.4

 

328.0

 

127.6

 

 

503.0

Total assets

$

5,986.2

$

6,223.0

$

3,891.9

$

(2,425.3)

$

13,675.8

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

$

382.8

$

170.5

$

(10.0)

$

543.3

Accrued expenses and other liabilities

 

18.6

 

184.0

 

121.9

 

0.1

 

324.6

Deferred revenues and income

 

 

348.9

 

100.3

 

 

449.2

Current maturities of corporate borrowings

 

20.0

 

 

 

 

20.0

Current maturities of finance lease liabilities

5.3

5.0

10.3

Current maturities of operating lease liabilities

449.5

136.3

585.8

Total current liabilities

 

38.6

 

1,370.5

 

534.0

 

(9.9)

 

1,933.2

Corporate borrowings

 

4,733.4

 

 

 

 

4,733.4

Finance lease liabilities

 

 

13.9

 

75.7

 

 

89.6

Operating lease liabilities

3,666.8

1,247.0

4,913.8

Exhibitor services agreement

 

 

549.7

 

 

 

549.7

Deferred tax liability, net

26.8

19.2

46.0

Other long-term liabilities

 

 

142.7

 

53.2

 

 

195.9

Total liabilities

 

4,772.0

 

5,770.4

 

1,929.1

 

(9.9)

 

12,461.6

Stockholders’ equity

 

1,214.2

 

452.6

 

1,962.8

 

(2,415.4)

 

1,214.2

Total liabilities and stockholders’ equity

$

5,986.2

$

6,223.0

$

3,891.9

$

(2,425.3)

$

13,675.8

Consolidating Balance Sheet

As of December 31, 2018:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Assets

    

    

    

    

    

    

    

    

    

    

Current assets:

Cash and cash equivalents

$

0.3

$

177.8

$

135.2

$

$

313.3

Restricted cash

10.7

10.7

Receivables, net

 

 

163.0

 

100.9

 

(4.4)

 

259.5

Other current assets

 

 

140.7

 

57.1

 

 

197.8

Total current assets

 

0.3

 

481.5

 

303.9

 

(4.4)

 

781.3

Investment in equity of subsidiaries

 

719.0

 

1,430.1

 

 

(2,149.1)

 

Property, net

 

 

2,152.3

 

887.3

 

 

3,039.6

Intangible assets, net

 

 

225.6

 

126.5

 

 

352.1

Intercompany advances

 

5,362.3

 

(4,512.3)

 

(850.0)

 

 

Goodwill

 

(2.1)

 

3,074.7

 

1,716.1

 

 

4,788.7

Deferred tax asset, net

 

 

 

28.6

 

 

28.6

Other long-term assets

 

59.8

 

316.2

 

129.5

 

 

505.5

Total assets

$

6,139.3

$

3,168.1

$

2,341.9

$

(2,153.5)

$

9,495.8

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

$

327.2

$

129.9

$

(4.5)

$

452.6

Accrued expenses and other liabilities

 

31.5

 

197.5

 

149.4

 

0.1

 

378.5

Deferred revenues and income

 

 

314.0

 

100.8

 

 

414.8

Current maturities of corporate borrowings

13.8

1.4

15.2

Current maturities of capital and financing lease obligations

 

 

38.6

 

28.4

 

 

67.0

Total current liabilities

 

45.3

 

878.7

 

408.5

 

(4.4)

 

1,328.1

Corporate borrowings

 

4,696.0

 

 

11.8

 

 

4,707.8

Capital and financing lease obligations

 

 

194.3

 

298.9

 

 

493.2

Exhibitor services agreement

 

 

564.0

 

 

 

564.0

Deferred tax liability, net

17.7

23.9

41.6

Other long-term liabilities

 

 

794.4

 

168.7

 

 

963.1

Total liabilities

 

4,741.3

 

2,449.1

 

911.8

 

(4.4)

 

8,097.8

Temporary equity

 

0.4

 

 

 

 

0.4

Stockholders’ equity

 

1,397.6

 

719.0

 

1,430.1

 

(2,149.1)

 

1,397.6

Total liabilities and stockholders’ equity

$

6,139.3

$

3,168.1

$

2,341.9

$

(2,153.5)

$

9,495.8

Consolidating Statement of Cash Flows

Year Ended December 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Cash flows from operating activities:

  

    

  

    

  

    

  

    

  

    

Net cash provided by operating activities

$

51.1

$

316.6

$

211.3

$

$

579.0

Cash flows from investing activities:

Capital expenditures

 

 

(369.4)

 

(148.7)

 

 

(518.1)

Acquisition of theatre assets

(11.8)

(11.8)

Proceeds from disposition of long-term assets

 

 

7.9

 

15.3

 

 

23.2

Investments in non-consolidated entities, net

 

 

(0.1)

 

(9.6)

 

 

(9.7)

Other, net

 

 

0.3

 

 

 

0.3

Net cash used in investing activities

 

 

(373.1)

 

(143.0)

 

 

(516.1)

Cash flows from financing activities:

Proceeds from issuance of Term Loan due 2026

1,990.0

1,990.0

Payment of principal Senior Secured Notes due 2023

(230.0)

(230.0)

Payment of principal Senior Subordinated Notes due 2022

(375.0)

(375.0)

Call premiums paid for Senior Secured Notes due 2023 and Senior Subordinated Notes due 2022

(15.9)

(15.9)

Principal payments under Term Loans due 2022 and 2023

 

(1,338.5)

 

 

 

 

(1,338.5)

Repayments under Revolving Credit Facility

(12.0)

(12.0)

Scheduled principal payments under Term Loans

(21.9)

(21.9)

Principal payments under finance lease obligations

(6.1)

(4.8)

(10.9)

Principal payments under promissory note

(1.4)

(1.4)

Cash used to pay deferred financing fees

 

(11.9)

 

 

 

 

(11.9)

Cash used to pay dividends

 

(84.1)

 

 

 

 

(84.1)

Taxes paid for restricted unit withholdings

(1.3)

(1.3)

Change in intercompany advances

16.1

3.1

(19.2)

Net cash used in financing activities

 

(72.5)

 

(4.4)

 

(36.0)

 

 

(112.9)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

21.4

 

(22.0)

 

2.1

 

 

1.5

Net increase (decrease) in cash and cash equivalents and restricted cash

 

(82.9)

 

34.4

 

 

(48.5)

Cash and cash equivalents and restricted cash at beginning of period

 

0.3

 

177.8

 

145.9

 

 

324.0

Cash and cash equivalents and restricted cash at end of period

$

0.3

$

94.9

$

180.3

$

$

275.5

Consolidating Statement of Cash Flows

Year Ended December 31, 2018:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Cash flows from operating activities:

    

    

    

    

  

    

    

    

 

    

Net cash provided by operating activities

$

7.2

$

369.8

$

146.2

$

$

523.2

Cash flows from investing activities:

Capital expenditures

 

 

(395.5)

 

(180.8)

 

 

(576.3)

Proceeds from sale leaseback transactions

50.1

50.1

Proceeds from disposition of NCM

162.5

162.5

Proceeds from Screenvision merger

45.8

45.8

Proceeds from disposition of long-term assets

8.5

5.7

14.2

Investments in non-consolidated entities, net

 

 

(11.4)

 

 

 

(11.4)

Other, net

 

 

(3.6)

 

1.5

 

 

(2.1)

Net cash used in investing activities

 

 

(143.6)

 

(173.6)

 

 

(317.2)

Cash flows from financing activities:

Proceeds from issuance of convertible note due 2024

600.0

600.0

Net borrowings under revolving credit facilities

12.1

12.1

Scheduled principal payments under Term Loans

 

(13.8)

 

 

 

 

(13.8)

Principal payments under capital and financing lease obligations

(39.8)

(31.2)

(71.0)

Principal payments under promissory note

(1.4)

(1.4)

Cash used to pay deferred financing fees

 

(15.5)

 

 

 

 

(15.5)

Cash used to pay dividends

 

(258.1)

 

 

 

 

(258.1)

Taxes paid for restricted unit withholdings

(1.7)

(1.7)

Retirement of Class B common stock

(423.6)

(423.6)

Purchase of treasury stock

(21.8)

(21.8)

Change in intercompany advances

167.1

(144.7)

(22.4)

Net cash provided by (used in) financing activities

 

32.6

 

(185.9)

 

(41.5)

 

 

(194.8)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

(40.6)

 

41.6

 

(6.5)

 

 

(5.5)

Net increase (decrease) in cash and cash equivalents and restricted cash

(0.8)

 

81.9

 

(75.4)

 

 

5.7

Cash and cash equivalents and restricted cash at beginning of period

 

1.1

 

95.9

 

221.3

 

 

318.3

Cash and cash equivalents and restricted cash at end of period

$

0.3

$

177.8

$

145.9

$

$

324.0

Consolidating Statement of Cash Flows

Year Ended December 31, 2017:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Cash flows from operating activities:

    

    

    

    

    

    

    

    

    

    

Net cash provided by (used in) operating activities

$

(10.2)

$

364.3

$

183.3

$

$

537.4

Cash flows from investing activities:

Capital expenditures

 

 

(543.8)

 

(83.0)

 

 

(626.8)

Acquisition of Nordic Cinemas Group, net of cash and restricted cash acquired

(654.9)

77.3

(577.6)

Proceeds from sale leaseback transactions

136.2

136.2

Proceeds from disposition of NCM

89.0

89.0

Proceeds from disposition of Open Road

 

 

9.2

 

 

 

9.2

Proceeds (disbursements) from disposition of long-term assets

 

34.9

 

(10.8)

 

 

24.1

Investments in non-consolidated entities, net

 

 

(11.1)

 

 

 

(11.1)

Other, net

 

 

(2.1)

 

(0.2)

 

 

(2.3)

Net cash used in investing activities

 

 

(942.6)

 

(16.7)

 

 

(959.3)

Cash flows from financing activities:

Proceeds from the issuance of Senior Subordinated Sterling Notes due 2024

327.8

327.8

Proceeds from the issuance of Senior Subordinated Notes due 2027

475.0

475.0

Payment of Nordic SEK Term Loan

(144.4)

(144.4)

Payment of Nordic EUR Term Loan

(169.5)

(169.5)

Net proceeds from equity offering

616.8

616.8

Principal payment of Bridge Loan due 2017

(350.0)

(350.0)

Scheduled principal payments under Term Loans

(12.6)

(12.6)

Principal payments under capital and financing lease obligations

(41.6)

(29.1)

 

(70.7)

Principal payments under promissory note

(1.4)

 

 

(1.4)

Cash used to pay deferred financing fees

(29.8)

(3.8)

(33.6)

Cash used to pay dividends

 

(104.6)

 

 

 

 

(104.6)

Taxes paid for restricted unit withholdings

(6.5)

 

 

(6.5)

Purchase of treasury stock

(34.0)

 

 

(34.0)

Change in intercompany advances

(616.7)

662.1

(45.4)

Net cash provided by (used) in financing activities

 

(48.5)

 

619.1

 

(78.3)

 

 

492.3

Effect of exchange rate changes on cash and equivalents

 

56.8

 

(53.5)

 

14.4

 

 

17.7

Net increase (decrease) in cash and equivalents

(1.9)

 

(12.7)

 

102.7

 

 

88.1

Cash and equivalents at beginning of period

 

3.0

 

108.6

 

118.6

 

 

230.2

Cash and equivalents at end of period

$

1.1

$

95.9

$

221.3

$

$

318.3